{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:42:41Z","timestamp":1772019761783,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.jpba.2009.12.011","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T14:13:26Z","timestamp":1261059206000},"page":"142-148","source":"Crossref","is-referenced-by-count":18,"title":["A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities"],"prefix":"10.1016","volume":"52","author":[{"given":"Prabha","family":"Srinivasu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devarakonda V.","family":"SubbaRao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju V.K.","family":"Vegesna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Sudhakar Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2009.12.011_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1749-6632.1984.tb12398.x","article-title":"The use of carbonic anhydrase inhibitors in ophthalmology and medicine","volume":"429","author":"Wistrand","year":"1984","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpba.2009.12.011_bib2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/archopht.1977.04450080088009","article-title":"Carbonic anhydrase inhibitor side effects: serum chemical analysis","volume":"95","author":"Epstein","year":"1997","journal-title":"Arch. Opthalmol."},{"key":"10.1016\/j.jpba.2009.12.011_bib3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0731-7085(98)00024-7","article-title":"Quantitation of acetazolamide in rat plasma, brain tissue and cerebrospinal fluid by high-performance liquid chromatography","volume":"17","author":"Ichikawa","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2009.12.011_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0731-7085(01)00615-X","article-title":"Rapid determination of acetazolamide in human plasma","volume":"28","author":"Zarghi","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2009.12.011_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0378-4347(92)80317-J","article-title":"Determination of acetazolamide in human urine samples by reversed-phase high-performance liquid chromatography in the presence of xanthines","volume":"582","author":"Herr\u00e1ez-Hern\u00e1ndez","year":"1992","journal-title":"J. Chromatogr. Biomed. Appl."},{"key":"10.1016\/j.jpba.2009.12.011_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0378-4347(94)00005-0","article-title":"Application of column-switching techniques to the determination of medium polarity drugs: determination of acetazolamide in urine","volume":"654","author":"Camp\u00edns-Falc\u00f3","year":"1994","journal-title":"J. Chromatogr. B: Biomed. Sci. Appl."},{"key":"10.1016\/j.jpba.2009.12.011_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1010-6030(98)00359-1","article-title":"Photolysis and photosensitized degradation of the diuretic drug acetazolamide","volume":"118","author":"Vargas","year":"1998","journal-title":"J. Photochem. Photobiol. A"},{"key":"10.1016\/j.jpba.2009.12.011_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ecoenv.2005.05.015","article-title":"Degradation and effects of the potential mosquito larvicides methazolamide and acetazolamide in sheepshead minnow (Cyprinodon variegatus)","volume":"64","author":"del Pilar Corena","year":"2006","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.jpba.2009.12.011_bib9","series-title":"Validation of Analytical Procedures: Text and Methodology","author":"ICH Q2 (R1)","year":"2005"},{"key":"10.1016\/j.jpba.2009.12.011_bib10","series-title":"Stability Testing of New Drug Substances and Products","author":"ICH Q1 (R2)","year":"2000"},{"key":"10.1016\/j.jpba.2009.12.011_bib11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0731-7085(02)00047-X","article-title":"Development of validated stability indicating assay methods\u2014critical review","volume":"28","author":"Bakshi","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2009.12.011_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1365\/s10337-007-0364-x","article-title":"A stability indicating LC method for Candesartan cilexetil","volume":"66","author":"Subbarao","year":"2007","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2009.12.011_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1365\/s10337-007-0478-1","article-title":"Stress degradation studies on Tadalafil and development of a validated stability indicating LC assay for bulk drug and pharmaceutical dosage form","volume":"67","author":"Subbarao","year":"2008","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2009.12.011_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1365\/s10337-008-0584-8","article-title":"Stress degradation studies on Dutasteride and development of a stability indicating HPLC assay for bulk drug and pharmaceutical dosage form","volume":"67","author":"Subbarao","year":"2008","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2009.12.011_bib15","series-title":"Drug Stability Principles and Practices","author":"Carstensen","year":"2000"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708509007377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708509007377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T13:50:18Z","timestamp":1544795418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708509007377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0731708509007377"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2009.12.011","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}